Meeting
2023 ASCO Annual Meeting
Survival outcomes of sarcomatoid versus classic urothelial carcinoma of bladder.
Authors
Rohan Garje
Miami Cancer Institute, Baptist Health South Florida, Miami, FL
Rohan Garje , Ahmad Ozair , Meenakkshy Manoharan , Pushan Prabhakar , Muni B. Rubens , Mukesh Roy , Anshul Saxena , Atulya Aman Khosla , Bruno R. Bastos , Manmeet Singh Ahluwalia
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Urothelial Cancer - Local-Regional Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 4588)
DOI
10.1200/JCO.2023.41.16_suppl.4588
Abstract #
4588
Poster Bd #
80
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Survival outcomes of micropapillary versus classic variant, loco-regional bladder cancer: A 2004-2019 National Cancer Database analysis.
First Author: Rohan Garje
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Effect of tumor location on the efficacy of chemotherapy for gastrointestinal stromal tumors.
First Author: Ryan Sweeney
Poster
2022 ASCO Annual Meeting
Dose intensity and outcomes of VDC/IE chemotherapy for adolescent and adult patients with Ewing’s family sarcoma.
First Author: Danielle Klingberg
Poster
2022 ASCO Genitourinary Cancers Symposium
Factors associated with improved outcomes in surgically resectable small cell urothelial cancer (SCUC).
First Author: Omar Alhalabi